Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary eosinophilic syndromes.

Michael E Wechsler1

  • 1Pulmonary & Critical Care Division, Harvard Medical School, Brigham & Women's Hospital, 15 Francis Street, Boston, MA 02115, USA. mwechsler@rics.bwh.harvard.edu

Immunology and Allergy Clinics of North America
|September 18, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined large and small airway obstruction is associated with increased exacerbation frequency and poorer symptom control in persistent asthma.

The journal of allergy and clinical immunology. In practice·2026
Same author

Patients' perspectives of eosinophilic granulomatosis with polyangiitis within the context of a clinical trial.

EULAR rheumatology open·2026
Same author

Reply to Siddiqui et al., Godbout et al., and to Chang and Mao.

American journal of respiratory and critical care medicine·2026
Same author

Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma.

Allergy·2026
Same author

Efficacy and safety of tezepelumab versus placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent asthma (SUNRISE): a multicentre, placebo-controlled, double-blind, phase 3 trial.

The Lancet. Respiratory medicine·2026
Same author

Real-world outcomes and corticosteroid sparing with mepolizumab for EGPA or HES.

The journal of allergy and clinical immunology. Global·2026
Same journal

Anaphylaxis: State-of-the-Art.

Immunology and allergy clinics of North America·2026
Same journal

Upending Impending Doom.

Immunology and allergy clinics of North America·2026
Same journal

Mast Cell Activation Syndrome and Mimickers.

Immunology and allergy clinics of North America·2026
Same journal

Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Emerging Therapies for Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Novel Epinephrine Delivery Devices.

Immunology and allergy clinics of North America·2026
See all related articles

Pulmonary eosinophilic syndromes involve increased eosinophils in the lungs and blood, causing respiratory issues and systemic effects. Prompt diagnosis and corticosteroid treatment are crucial to prevent lasting lung damage.

Area of Science:

  • Pulmonology
  • Hematology
  • Immunology

Background:

  • Pulmonary eosinophilic syndromes (PES) encompass conditions like acute eosinophilic pneumonia, chronic eosinophilia, Churg-Strauss syndrome, and hypereosinophilic syndrome.
  • These syndromes are defined by elevated eosinophil counts in blood, lung tissue, sputum, or bronchoalveolar lavage fluid.
  • PES often presents with respiratory symptoms, abnormal chest imaging, and potential systemic involvement.

Purpose of the Study:

  • To summarize the key characteristics of pulmonary eosinophilic syndromes.
  • To emphasize the importance of differentiating PES from other causes of eosinophilia in lung disease.
  • To highlight the critical need for timely diagnosis and aggressive treatment of PES.

Main Methods:

  • Review of existing literature and clinical data on pulmonary eosinophilic syndromes.

Related Experiment Videos

  • Analysis of diagnostic criteria, clinical manifestations, and treatment outcomes.
  • Emphasis on differential diagnosis and management strategies.

    • Main Results:

    • Pulmonary eosinophilic syndromes share common features including eosinophilia and respiratory symptoms.
    • Systemic manifestations can occur, necessitating a comprehensive patient evaluation.
    • Exclusion of other causes of eosinophilia is a critical diagnostic step.

    Conclusions:

    • Prompt diagnosis and aggressive treatment, primarily with corticosteroids, are essential for managing PES.
    • Early intervention aims to prevent long-term pulmonary sequelae and systemic complications.
    • A thorough diagnostic approach is vital for effective patient management.